Antiandrogens in Prostate Cancer Endocrine Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|5|455-461

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.5, 2004-08, pp. : 455-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perspectives on designs of antiandrogens for prostate cancer

By EstÉbanez-PerpiñÁ Eva   Jouravel Natalia   Fletterick Robert J  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 10, 2007-10 ,pp. : 1341-1355

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of Antiandrogens in the Treatment of Prostate Cancer

By Fourcade R.-O.   McLeod D.  

UroOncology, Vol. 4, Iss. 1, 2004-03 ,pp. : 5-13

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer

By Mahler C.   Verhelst J.   Denis L.  

Clinical Pharmacokinetics, Vol. 34, Iss. 5, 1998-05 ,pp. : 405-417

Adis International

Access to resources Recommend Favorite

Value of Endocrine Therapy for Early and Locally Advanced Prostate Cancer

By Wirth M.P.   Froehner M.  

Drugs & Aging, Vol. 20, Iss. 2, 2003-01 ,pp. : 115-124

Adis International

Access to resources Recommend Favorite

Do antiandrogens improve survival in prostate cancer?

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite